• Koray Koşmaz, Abdullah Durhan, Marlen Süleyman, Yılmaz Ünal, Mustafa Taner Bostancı, Tuğba Yiğit Haskaraca, Can Ersak, Mehmet Şener, İlknur Alkan Kuşabbi, Eylem Pınar Eser, and Sema Hücümenoğlu.
• Department of General Surgery, Ankara Education and Research Hospital, Ankara, Turkey
• Turk J Med Sci. 2021 Jun 28; 51 (3): 147214801472-1480.

Background/AimsTo evaluate the potential protective effects of Ankaferd blood stopper (ABS) in an experimental obstructive jaundice (OJ) model.Materials And MethodsThe study included 26 female rats, which were divided into 3 groups. The sham group, consisting of 10 rats, (group 1) only received solely laparotomy. In the control group, consisting of 8 rats, (group 2), ligation was applied to the biliary tract and no treatment was implemented. In the treatment group, consisting of 8 rats, (group 3), following ligation of biliary tract, 0.5 mL/day ABS was given for 10 days. Liver tissue and blood samples were taken for histopathological and biochemical examination.ResultsCompared to group 2, group 3 had higher aspartate aminotransferase (AST), total oxidant status (TOS) malondialdehyde (MDA), fluorescent oxidant products (FOP), and lower expression of albumin and total antioxidant status (TAS) (P < 0.05). In histopathological analysis, the mean scores of all histopathological parameters (fibrosis, portal inflammation, confluent necrosis, interphase activity, bile duct proliferation) have statistical significance between group 2 and group 3 (P < 005).ConclusionsABS has promising results in the treatment of experimental OJ because of its antioxidant and antiinflammatory properties. It may be used in clinical practice after more extensive studies about the effects of ABS on OJ.This work is licensed under a Creative Commons Attribution 4.0 International License.

18 keywords...

hide…